ARCHIVES

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993

Adamson Is Named Acting Deputy; Broder Begins Search For Roper Replacement

May 25, 1990

NCI Director asks NCAB to pray for him.

June 18, 2004

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

O’Neill Account, Kennedy Hearing, Create Climate On Capitol Hill for Increasing Cancer Funding

May 3, 1991